Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.

作者: Michael F. Sugrue

DOI: 10.1016/0163-7258(83)90065-7

关键词:

摘要: Abstract Acutely administered antidepressants possess a multiplicity of pharmacological actions. However, the fact that agents possessing similar actions are devoid antidepressant activity, together with lack correlation between doses required for acute effects and clinical efficacy, suggest mechanism(s) action cannot be directly attributed to properties drugs. The lag phase in onset effectiveness emphasizes importance adaptive changes following chronic administration. A rapidly accelerating trend attempting delineate precise molecular mechanisms is shift emphasis therapies from alterations uptake, storage, synthesis release neurotransmitters receptor functioning. These adaptations occur both pre- postsynaptically. Examples former alpha 2 DA presynaptic receptors, being down-regulated by certain forms therapy. NE-coupled adenylate cyclase system rat brain slices tricyclics, atypical antidepressants, MAO inhibitors ECT system. Electrophysiological behavioral studies point up-regulation central 1 5-HT functioning long-term In contrast beta-adrenoceptor, these findings correlated data radioligand binding studies. general -adrenoceptor remains unaltered. This also true whereas cortical increased decreased depending on type therapy investigated. relationship efficacy man not clear since there generally good models studying human review current animal would tend disfavour view all common mechanism action. Perhaps multiple intervention sites exist. introduction evaluation specificity will undoubtedly aid psychotherapeutic research. knowledge peptides ‘classical’ can co-exist same neurone generate significance co-transmitter function therapies.

参考文章(298)
Torgny H. Svensson, Ted Usdin, ALPHA-ADRENORECEPTOR MEDIATED INHIBITION OF BRAIN NORADRENERGIC NEURONS AFTER ACUTE AND CHRONIC TREATMENT WITH TRICYCLIC ANTIDEPRESSANTS Catecholamines: Basic and Clinical Frontiers#R##N#Proceedings of the Fourth International Catecholamine Symposium, Pacific Grove, California, September 17-22, 1978. pp. 672- 674 ,(1979) , 10.1016/B978-1-4832-8363-0.50204-4
Jack Peter Green, Histamine Receptors in Brain Springer, Boston, MA. pp. 385- 420 ,(1983) , 10.1007/978-1-4684-4361-5_8
M. I. Gluckman, T. Baum, The pharmacology of iprindole, a new antidepressant Psychopharmacology. ,vol. 15, pp. 169- 185 ,(1969) , 10.1007/BF00411167
V. Homburger, M. Lucas, B. Cantau, J. Barabe, J. Penit, J. Bockaert, Further evidence that desensitization of beta-adrenergic-sensitive adenylate cyclase proceeds in two steps. Modification of the coupling and loss of beta-adrenergic receptors. Journal of Biological Chemistry. ,vol. 255, pp. 10436- 10444 ,(1980) , 10.1016/S0021-9258(19)70483-9
ROBERT M. POST, JOEL KOTIN, FREDERICK K. GOODWIN, The effects of cocaine on depressed patients. American Journal of Psychiatry. ,vol. 131, pp. 511- 517 ,(1974) , 10.1176/AJP.131.5.511
S. J. Peroutka, Solomon H Snyder, Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline. Journal of Pharmacology and Experimental Therapeutics. ,vol. 215, pp. 582- 587 ,(1980)
S Z Langer, Presynaptic regulation of the release of catecholamines. Pharmacological Reviews. ,vol. 32, pp. 337- 362 ,(1980)
M Hermoni, R H Belmaker, R P Ebstein, The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain: inhibition after chronic treatment and absence of supersensitivity. Journal of Pharmacology and Experimental Therapeutics. ,vol. 213, pp. 161- 167 ,(1980)